©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 112475
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112475
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112475
Figure 3 Fibroblast growth factor 1 attenuates lipid accumulation in the kidneys of type 2 diabetes mellitus mice.
A: Plasma triglyceride levels; B: Triglyceride content in kidney tissue; C: Adipose differentiation related protein (ADRP) mRNA expression analyzed by RT-qPCR; D: ADRP expression in the kidney assessed by immunohistochemistry; E: Quantification of ADRP immunostaining. Data were presented as mean ± SD. aP < 0.05. Bar = 100 μm. ADPR: Adipose differentiation related protein; Ctrl: Control; FGF1: Fibroblast growth factor 1; T2DM: Type 2 diabetes mellitus.
- Citation: Li YJ, Ge HY, Zhang GG, Chen HY, Xi YJ, Wang K, Huang YL, Zhang C, Fan X, Yan XQ. Fibroblast growth factor 1 alleviates diabetic nephropathy by reducing renal lipid accumulation in diabetic kidney. World J Diabetes 2026; 17(2): 112475
- URL: https://www.wjgnet.com/1948-9358/full/v17/i2/112475.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i2.112475